Refresh

Aarti Pharmalabs Ltd. - Research Center

543748 AARTIPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21
Income

Operating income

1,511.25 941.02 -
Expenses

Material consumed

759.17 491.80 -

Manufacturing expenses

282.54 167.97 -

Personnel expenses

122.16 79.98 -

Selling expenses

5.13 0.31 -

Adminstrative expenses

33.92 21.16 -

Expenses capitalised

- - -

Cost of sales

1,202.91 761.24 -

Operating profit

308.34 179.79 -

Other recurring income

1.28 2.51 -

Adjusted PBDIT

309.62 182.30 -

Financial expenses

20.49 11.34 -

Depreciation

55.77 37.23 -

Other write offs

- - -

Adjusted PBT

233.36 133.73 -

Tax charges

61.63 27.00 -

Adjusted PAT

171.73 106.73 -

Non recurring items

- - -

Other non cash adjustments

- - -

Reported net profit

171.73 106.73 -

Earnigs before appropriation

877.67 705.95 -0.02

Equity dividend

18.13 - -

Preference dividend

- - -

Dividend tax

- - -

Retained earnings

859.55 705.95 -0.02
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com